Scientia Advisors to Present at the Stem Cell Manufacturing Workshop

Cambridge, MA, November 24, 2008 --(PR.com)-- Arshad Ahmed, a Partner at Scientia Advisors, will deliver a presentation on Business Models for Cell Therapies at the Stem Cell Biomanufacturing Workshop hosted by the Parker H. Petit Institute for Bioengineering and Bioscience at Georgia Tech on December 16th, 2008. Mr. Ahmed’s presentation will cover a series of topics on cell therapy, including:

Current condition and developments within the cell therapy market
Competitive landscape of the market
In depth analysis of current business models

The Stem Cell Biomanufacturing Workshop is an international consortium designed to develop and identify technologies to advance large scale manufacturing of stem cells. The consortium will bring together experts in academia and industry to discuss the future of stem cell development.

The event will be hosted at the Georgia Tech Hotel and Conference Center from December 14th-16th, 2008. For more information please visit: biomanufacturing.ibb.gatech.edu/index.php

Arshad Ahmed has over fifteen years of strategic management consulting experience in life sciences, environmental and health care markets. He has focused on strategic planning, corporate development, strategic transactions advisory and operational improvement issues for clients across various life and environmental sectors including diagnostics, drug discovery, applied industrial markets as well as therapeutics and bio-production. For drug discovery and diagnostic clients his engagements have involved developing and implementing comprehensive go-to-market plans in the areas of genomics, proteomics, cell biology, in vivo pre-clinical testing, molecular diagnostics, pharmacogenomics as well as food and water testing in the applied area. From a disease perspective, Mr. Ahmed's has focused his efforts on identifying market needs in Infectious Disease, Oncology and Cardiovascular markets and analyzed technological disruption that these therapeutics areas will face over the next several years.

###